Earnings reports are critical events that directly impact a company's stock price. Negative or below-expectation results typically lead to a decrease in share price, as they may indicate operational or financial challenges. Given that MiNK Therapeutics' shares are trading lower following the announcement, it suggests the market's reaction is negative, likely due to results not meeting investor expectations.